152 results on '"Khan, Muhammad Shahzeb"'
Search Results
2. From Hospital to Home: Evidence-Based Care for Worsening Heart Failure
3. Interleukin-6 and Cardiovascular Events in Healthy Adults: MESA
4. Eligibility and Projected Benefits of Rapid Initiation of Quadruple Therapy for Newly Diagnosed Heart Failure
5. Trends in cancer and heart failure related mortality in adult US population: A CDC WONDER database analysis from 1999 to 2020
6. Effect of SGLT2 inhibitors on heart failure outcomes and cardiovascular death across the cardiometabolic disease spectrum: a systematic review and meta-analysis
7. Nano-based remediation strategies for micro and nanoplastic pollution
8. Prevalence and Predictors of Readmissions in Patients With Hypertrophic Cardiomyopathy and Atrial Fibrillation/Flutter
9. Patterns, Prognostic Implications, and Rural-Urban Disparities in Optimal GDMT Following HFrEF Diagnosis Among Medicare Beneficiaries
10. A Phenomapping Tool and Clinical Score to Identify Low Diuretic Efficiency in Acute Decompensated Heart Failure
11. Natriuretic Peptides and Prognosis in Patients With Type 2 Diabetes Mellitus and High Risk for Cardiovascular Events
12. Bridging gaps and optimizing implementation of guideline-directed medical therapy for heart failure
13. The spectrum of post-myocardial infarction care: From acute ischemia to heart failure
14. Polypharmacy and Optimization of Guideline-Directed Medical Therapy in Heart Failure: The GUIDE-IT Trial
15. Frailty and Its Implications in Heart Failure with Reduced Ejection Fraction: Impact on Prognosis and Treatment
16. Vascular Disease Burden, Outcomes and Benefits with Empagliflozin in Heart Failure: Insights From the EMPEROR-Reduced Trial
17. Comparison of 30-day Readmission Rates and Inpatient Cardiac Procedures for Weekday Versus Weekend Hospital Admissions for Heart Failure
18. Association of Chronic Renal Insufficiency with Inhospital Outcomes in Primary Heart Failure Hospitalizations (Insights from the National Inpatient Sample 2004 to 2018)
19. Implementing Guideline-Directed Medical Therapy for Heart Failure: JACC Focus Seminar 1/3
20. Association of Non-Alcoholic Fatty Liver Disease With in-Hospital Outcomes in Primary Heart Failure Hospitalizations With Reduced or Preserved Ejection Fraction
21. An Individual Patient-Level Meta-Analysis of Ischemic Versus Nonischemic Cardiomyopathy and Trajectory of Decongestion in Patients With Acute Decompensated Heart Failure
22. Predicting and preventing heart failure in type 2 diabetes
23. Utilization Rates of SGLT2 Inhibitors Among Patients With Type 2 Diabetes, Heart Failure, and Atherosclerotic Cardiovascular Disease: Insights From the Department of Veterans Affairs
24. In Silico modeling and exploration of new acceptor molecules with enhanced power conversion efficiency for high-performance organic solar cell applications
25. Effect of Canagliflozin on Heart Failure Hospitalization in Diabetes According to Baseline Heart Failure Risk
26. Demographic and Regional Trends of Cardiovascular Diseases and Diabetes Mellitus-Related Mortality in the United States From 1999 to 2019
27. Effect of SGLT2 Inhibitors on Cardiovascular Outcomes Across Various Patient Populations
28. Minimal Clinically Important Differences in 6-Minute Walk Test in Patients With HFrEF and Iron Deficiency
29. Ejection Fraction, Biomarkers, and Outcomes and Impact of Vericiguat on Outcomes Across EF in VICTORIA
30. Management of Heart Failure With Reduced Ejection Fraction in Patients With Diabetes Mellitus and Chronic Kidney Disease
31. Inconsistent Outcome Reporting in Heart Failure Randomized Controlled Trials
32. Medication-Attributable Adverse Events in Heart Failure Trials
33. Combustion and emission characterization of upgraded biomass fast pyrolysis oil in a swirl burner
34. CuO-decorated MOF derived ZnO polyhedral nanostructures for exceptional H2S gas detection
35. The state of health in Pakistan and its provinces and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019
36. Applicability of Vericiguat to Patients Hospitalized for Heart Failure in the United States
37. Metal-organic framework-based smart nanoplatforms for biosensing, drug delivery, and cancer theranostics
38. Synergistic effects of doping, composite formation, and nanotechnology to enhance the photocatalytic activities of semiconductive materials
39. Managing Heart Failure in Patients on Dialysis: State-of-the-Art Review
40. Preload Reduction Therapies in Heart Failure
41. Trends in Heart Failure–Related Mortality Among Older Adults in the United States From 1999-2019
42. Cellulose and its derivatives, coffee grounds, and cross-linked, β-cyclodextrin in the race for the highest sorption capacity of cationic dyes in accordance with the principles of sustainable development
43. A Systematic Review of Sex-Specific Reporting in Heart Failure Clinical Trials: Trial Flow and Results
44. Subjective Financial Hardship due to Medical Bills Among Patients With Heart Failure in the United States: The 2014–2018 Medical Expenditure Panel Survey
45. Trends in HF Hospitalizations Among Young Adults in the United States From 2004 to 2018
46. The prognostic implications of ST-segment and T-wave abnormalities in patients undergoing regadenoson stress SPECT myocardial perfusion imaging
47. Frailty, Guideline-Directed Medical Therapy, and Outcomes in HFrEF: From the GUIDE-IT Trial
48. Clinical Outcomes With Metformin and Sulfonylurea Therapies Among Patients With Heart Failure and Diabetes
49. The effect of preheating of a viscous and non-Newtonian bioliquid on its internally mixed twin-fluid atomization
50. Trends in hospitalizations for heart failure, acute myocardial infarction, and stroke in the United States from 2004 to 2018
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.